Gastroparesis is a severe disorder that causes food to move too slowly through the stomach to the small intestine
While patients may also notice cloudy, dark, or foul-smelling urine, or hematuria (blood in the urine), these findings alone are not diagnostic and should be evaluated alongside other symptoms
Note you should not take Wegovy if: you are pregnant or trying to conceive you are breastfeeding your BMI is below 30, or below 27, and you do not have a weight-related medical condition you have ever had a serious allergic reaction to any of the ingredients in Wegovy, especially semaglutide Wegovy is also cautioned in some people, such as those with: diabetic retinopathy a history of pancreatitis severe, congestive heart failure You should speak to your doctor before using Wegovy pens if you have: kidney problems diabetes inflammation of your pancreas low blood sugar levels (hypoglycaemia) diabetic eye disease (retinopathy) A doctor may not be able to prescribe Wegovy in these cases
In such cases, new GLP-1 receptor agonist (RA) weight loss medications might be beneficial because weight regain or inadequate weight loss limits the health benefits of surgery
These potential synergies indicate that H could be strategically integrated as an adjunct to existing treatment regimens, enhancing neuroprotection and functional outcomes